AU741635B2 - Prognostic allergy or inflammation test - Google Patents

Prognostic allergy or inflammation test Download PDF

Info

Publication number
AU741635B2
AU741635B2 AU23478/99A AU2347899A AU741635B2 AU 741635 B2 AU741635 B2 AU 741635B2 AU 23478/99 A AU23478/99 A AU 23478/99A AU 2347899 A AU2347899 A AU 2347899A AU 741635 B2 AU741635 B2 AU 741635B2
Authority
AU
Australia
Prior art keywords
epitopes
antibodies
food
ige
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU23478/99A
Other languages
English (en)
Other versions
AU2347899A (en
Inventor
Hugh A. Sampson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALLERTEIN THERAPEUTICS LLC
Original Assignee
ALLERTEIN THERAPEUTICS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALLERTEIN THERAPEUTICS LLC filed Critical ALLERTEIN THERAPEUTICS LLC
Publication of AU2347899A publication Critical patent/AU2347899A/en
Application granted granted Critical
Publication of AU741635B2 publication Critical patent/AU741635B2/en
Assigned to ALLERTEIN THERAPEUTICS, LLC reassignment ALLERTEIN THERAPEUTICS, LLC Alteration of Name(s) in Register under S187 Assignors: SAMPSON, HUGH A.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AU23478/99A 1998-01-30 1999-01-28 Prognostic allergy or inflammation test Ceased AU741635B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7317198P 1998-01-30 1998-01-30
US60/073171 1998-01-30
PCT/US1999/001832 WO1999039211A1 (en) 1998-01-30 1999-01-28 Prognostic allergy or inflammation test

Publications (2)

Publication Number Publication Date
AU2347899A AU2347899A (en) 1999-08-16
AU741635B2 true AU741635B2 (en) 2001-12-06

Family

ID=22112157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23478/99A Ceased AU741635B2 (en) 1998-01-30 1999-01-28 Prognostic allergy or inflammation test

Country Status (9)

Country Link
US (1) US6238925B1 (enExample)
EP (2) EP1939628B1 (enExample)
JP (1) JP4292262B2 (enExample)
AT (2) ATE550665T1 (enExample)
AU (1) AU741635B2 (enExample)
CA (1) CA2319317C (enExample)
DE (1) DE69919327D1 (enExample)
ES (2) ES2229673T3 (enExample)
WO (1) WO1999039211A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
RU2214599C2 (ru) * 2001-11-21 2003-10-20 Самарский медицинский институт "РЕАВИЗ" Способ выявления лиц, относящихся к группе риска по развитию аллергических заболеваний
MXPA05011409A (es) * 2003-04-23 2005-12-12 Medarex Inc Composiciones y metodos para la terapia de enfermedad inflamatoria intestinal.
US7662381B2 (en) 2004-06-21 2010-02-16 Medarex, Inc. Interferon alpha receptor 1 antibodies and their uses
US8859210B2 (en) * 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
WO2010101255A1 (ja) * 2009-03-05 2010-09-10 味の素株式会社 クローン病診断試薬
EP2478373B1 (en) * 2009-09-14 2019-01-09 Icahn School of Medicine at Mount Sinai Methods for characterizing antibody binding affinity and epitope diversity in food allergy
WO2012135313A1 (en) * 2011-03-28 2012-10-04 University Of Massachusetts Compositions and methods for detecting allergy to a-gal epitopes
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
EP3760223A1 (en) 2013-04-03 2021-01-06 N-Fold Llc Nanoparticle composition for desensitizing a subject to peanut allergens
KR102202575B1 (ko) 2013-12-31 2021-01-13 삼성전자주식회사 메모리 관리 방법 및 장치
US11215615B2 (en) 2014-04-03 2022-01-04 AllerGenis LLC Peptides, reagents and methods for detecting food allergy
SG11201705102QA (en) 2014-11-14 2017-07-28 Biomerica Inc Compositions, devices, and methods of ibs sensitivity testing
EP3173789A1 (en) * 2015-11-24 2017-05-31 Helmholtz-Zentrum für Infektionsforschung GmbH Method for differentiation of immune response in an individual
JP2019515275A (ja) * 2016-04-26 2019-06-06 バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． 潰瘍性大腸炎感受性試験の組成物、デバイスおよび方法
US11686733B2 (en) * 2016-05-13 2023-06-27 Applied Medical Enzyme Research Institute Corporation Method for collecting data to predict risk of developing allergies
RU2621312C1 (ru) * 2016-06-15 2017-06-01 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста
KR102687458B1 (ko) * 2016-06-16 2024-07-24 호유 가부시키가이샤 생선 알레르기의 항원
CN109804247A (zh) 2016-07-08 2019-05-24 拜尔梅里科有限公司 抑郁症敏感测试的组合物、设备以及方法
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒
US11237164B2 (en) * 2020-04-15 2022-02-01 ProteinSimple Method for measurement of total protein content and detection of protein via immunoassay in a microfluidic device
US20230324405A1 (en) * 2020-09-07 2023-10-12 Mitsubishi Gas Chemical Company, Inc. Allergic disease determination method and determination system
JP7555788B2 (ja) * 2020-10-30 2024-09-25 アサヒグループホールディングス株式会社 タンパク質の起源種判別方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017677A1 (en) * 1993-12-20 1995-06-29 Calenoff Emanuel J Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
US5939283A (en) * 1992-12-31 1999-08-17 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017677A1 (en) * 1993-12-20 1995-06-29 Calenoff Emanuel J Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STANLEY, J.S ET AL. ARCH. BIOCHEM AND BIOPHYS. 342(2) (1997) P244-253 *

Also Published As

Publication number Publication date
ES2383002T3 (es) 2012-06-15
EP1051626B1 (en) 2009-03-18
AU2347899A (en) 1999-08-16
ES2229673T3 (es) 2009-08-04
EP1939628A1 (en) 2008-07-02
ATE550665T1 (de) 2012-04-15
HK1032262A1 (en) 2001-07-13
JP4292262B2 (ja) 2009-07-08
CA2319317A1 (en) 1999-08-05
DE69919327T2 (de) 2005-03-10
US6238925B1 (en) 2001-05-29
DE69919327D1 (de) 2009-11-26
JP2002502039A (ja) 2002-01-22
EP1939628B1 (en) 2012-03-21
HK1120865A1 (en) 2009-04-09
EP1051626A1 (en) 2000-11-15
ATE426170T1 (de) 2009-04-15
CA2319317C (en) 2006-04-18
WO1999039211A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
AU741635B2 (en) Prognostic allergy or inflammation test
Järvinen et al. Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy
Hattevig et al. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non‐atopic children
EP2478373B1 (en) Methods for characterizing antibody binding affinity and epitope diversity in food allergy
US20150168389A1 (en) Methods Of Determining Allergen Response Using Microarray Immunoassay Techniques
EP2136211B1 (en) Determination method for allergic disease
Komata et al. Usefulness of wheat and soybean specific IgE antibody titers for the diagnosis of food allergy
Kemeny et al. The IgE and IgG subclass antibody response to foods in babies during the first year of life and their relationship to feeding regimen and the development of food allergy
US7258994B2 (en) Saliva immunoassay for detection of antibodies for cardiovascular disease
JP4958369B2 (ja) 食物アレルゲン、食物アレルゲンの検出方法及び食物アレルギー誘発性食品の検出方法
JP5633721B2 (ja) 乳幼児のアレルギー発症を予測するためのデータを提供する方法
Hoffmanc et al. Serum specific‐IgE antibodies to peptides detected in a casein hydrolysate formula
JP7385302B2 (ja) アナフィラキシーの発症を予測するためのデータを収集する方法
HK1032262B (en) Prognostic allergy or inflammation test
Germano et al. Specific humoral response to cows’ milk proteins and ovalbumin in children with atopic dermatitis
HK1120865B (en) Prognostic allergy test
JP2022096812A (ja) 抗原ポリペプチド
JP7585025B2 (ja) 歯周病原菌に対する抗体価を測定する方法
US7977063B2 (en) Method for determining an allergic response
Hamilton In vitro diagnostic methods in the evaluation of food hypersensitivity
Laan et al. MARKERS FOR EARLY SENSITISATION AND INFLAMMATION
Sekerkova et al. Research Article High Prevalence of Neutrophil Cytoplasmic Autoantibodies in Infants with Food Protein-Induced Proctitis/Proctocolitis: Autoimmunity Involvement?

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)